Mandate

VINGE ADVISES MVI EQUITY AB

July 01, 2014

Vinge has advised MVI Equity AB in connection with the joint acquisition together with Fouriertransform AB of SMP Parts, a leading designer and manufacturer of high quality machinery and accessories for excavators and loaders.

MVI Equity AB is an investment company which focuses on investments in medium-sized quality companies. MVI Equity AB consists of 100 entrepreneurs and managers who have invested in unlisted companies for more than 20 years. For more information, visit www.mvi.se.

Fouriertransform is a state-financed venture capital company which commercially supports innovative companies and entrepreneurs who can contribute to vitalizing the Swedish manufacturing industry.

Vinge’s team consisted of responsible partner Henrik Wenckert, partner Bo Adrianzon and, among others, associates Ulrich Ziche, Anna Lonergan and Malin Buch.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025